Section A – KMP Resignation Details

Dr. Ellen Jane Feehan Resignation

  • Name of Resigning KMP: Dr. Ellen Jane Feehan
  • Designation: Executive Director & Chief Executive Officer
  • Reason for Resignation: Unavoidable personal health reasons
  • Effective Date of Resignation: 24th September 2026
  • Date of Resignation Letter: 24th September 2026
  • Duration in Role: Not yet joined - employment agreement terminated before joining
  • Regulatory Compliance Statement: Disclosure made under Regulation 30 read with Clause 7C of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Analytical Context: Resignation occurred before the executive joined the company, terminating the Executive Employment Agreement made on 1st July 2026 and signed on 6th July 2026. Dr. Feehan was scheduled to join on 1st October 2026 but could not take up the assignment due to health reasons.

Dr. Neeraja Nagarajan Resignation

  • Name of Resigning KMP: Dr. Neeraja Nagarajan
  • Designation: Executive Director & Chief Operating Officer
  • Reason for Resignation: Non-alignment of Dr. Ellen Feehan as CEO (with whom she was supposed to synergize and team up), differentials in leadership styles and cultures, and operating model given domicile requirements
  • Effective Date of Resignation: 24th September 2026 (with immediate effect)
  • Date of Resignation Letter: 24th September 2026
  • Additional Details: Resigned from all roles and responsibilities across PVP Ventures Limited (Evervie Health Limited) and other group entity concerns, including participation in the Board. Returned official vehicle on resignation date.
  • Regulatory Compliance Statement: Disclosure made under Regulation 30 read with Clause 7C of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Analytical Context: Resignation appears strategically motivated by leadership structure changes and cultural misalignment. The executive cited need to balance professional pursuits with personal demands (family in the United States).

Section B – Additional Observations

  • Transition Details: No immediate replacement appointments announced for either position. Dr. Nagarajan has already returned company assets (official vehicle).
  • Board Acknowledgement: The Chairman and Managing Director, Prasad V. Potluri, signed the disclosure document acknowledging both resignations.

Section C – Financial & Governance Disclosures

Not Specified